ANXA5 and atrial fibrillation: Activation of ANXA5 by Docetaxel (score:91.44), inhibition of EIF5A by Fulvestrant (score: 94.15), and inhibition of GNA12 by Tamoxifen (score:93.41) increased the risk of AF.